Clinical Trial Update: Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing vedolizumab monotherapy to combination therapy with tacrolimus in ulcerative colitis was terminated; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Tacrolimus (Tacrolimus)
• Vedolizumab (vedolizumab)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED | Results posted: 2020-09-03